SLE

Currently Recruiting

Inclusion Summary

SLE Study 1

• SLE ≥24 weeks prior
• Currently receiving 1 of the following treatments:
• oral prednisone.
• Or any of
  – Azathioprine,
  – Antimalaria,
  – Mycophenolate mofetil,
  – mycophenolic acid,
  – methotrexate,
  – Mizoribine

No history of latent or active TB prior

Screening will assess criterias:

- ACR classification for SLE.

- BILAG-2004 Level

- SLEDAI-2K Criteria